title: Dolutegravir in breast milk and maternal and infant plasma during breastfeeding.
authors: aDepartment of Pediatrics, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany bDepartment of Pharmacy, Radboud University Medical Center cRadboud Institute for Health Sciences, Nijmegen, The Netherlands dHeinrich Pette Institute - Leibniz Institute for Experimental Virology eGerman Center for Infection Research (DZIF) fDepartment of Obstetrics and Fetal Medicine, University Medical Center Hamburg-Eppendorf gDepartment of Medicine, Infectious Disease Unit, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
authors: Robin
authors: R
authors: Kobbe
authors: Stein
authors: S
authors: Schalkwijk
authors: Gabor
authors: G
authors: Dunay
authors: Johanna M
authors: JM
authors: Eberhard
authors: Ulf
authors: U
authors: Schulze-Sturm
authors: Bettina
authors: B
authors: Hollwitz
authors: Olaf
authors: O
authors: Degen
authors: Marga
authors: M
authors: Teulen
authors: Angela
authors: A
authors: Colbers
authors: David
authors: D
authors: Burger
mesh_terms: D000328:Adult; D001942:Breast Feeding; D005260:Female; D019428:HIV Integrase Inhibitors / Q000032:analysis* / Q000493:pharmacokinetics; D006679:HIV Seropositivity / Q000188:drug therapy* / Q000378:metabolism; D006575:Heterocyclic Compounds, 3-Ring / Q000032:analysis* / Q000493:pharmacokinetics; D006801:Humans; D007223:Infant; D008895:Milk, Human / Q000737:chemistry*; D010078:Oxazines; D010879:Piperazines; D011728:Pyridones; D000099226:Dolutegravir
chemical_list: D019428:HIV Integrase Inhibitors; D006575:Heterocyclic Compounds, 3-Ring; D010078:Oxazines; D010879:Piperazines; D011728:Pyridones; D000099226:Dolutegravir